Skip to main content

Vitorovic Stefan's Form 4 filing

Vigil Neuroscience, Inc.VIGL · filed Jan 11, 2022

Accession no.
0000899243-22-001650
Filed
Jan 11, 2022
Trade date
Jan 11, 2022
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market purchases total $23.4M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Vitorovic StefanCIK 0001826967Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 11, 2022Common StockCConversionAcquired+3,333,245–F1–3,333,245Indirect
Jan 11, 2022Common StockCConversionAcquired+7,684–F1–7,684Indirect
Jan 11, 2022Common StockPPurchaseAcquired+1,671,148$14.00F4+$23,396,0725,004,393Indirect
Jan 11, 2022Common StockPPurchaseAcquired+3,852$14.00F5+$53,92811,536Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 11, 2022Common StockCConversionDisposed−3,333,245$0.00$00Indirect
Jan 11, 2022Common StockCConversionDisposed−7,684$0.00$00Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.

Referenced by the price of 2 transactions in Table I.

F4

On January 11, 2022, Vida III purchased 1,671,148 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.

Referenced by the price of 1 transaction in Table I.

F5

On January 11, 2022, Vida III-A purchased 3,852 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)